We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mutation for Hereditary Atrial Fibrillation Identified

By Biotechdaily staff writers
Posted on 24 Jan 2003
Researchers have found that a rare inherited form of atrial fibrillation (AF) is caused by a mutation in the KCNQ1 gene that encodes an ion channel subunit protein. More...
Their finding was published in the January 10, 2003, issue of Science.

Nearly one out of every 20 individuals over age 65 suffers from cardiac arrhythmia, which is increasing in prevalence as the population ages. Untreated AF can lead to heart muscle dysfunction, embolism, ventricular arrhythmia, and heart failure. Investigators studied a four-generation family in China with a history of AF. Of the 44 living members of this family from rural villages, 16 have cases of AF, all of which the researchers confirmed were hereditary. Gene mapping studies led the researchers to a region of chromosome 11 that was linked to AF. Sequence analysis revealed that there was a specific nucleotide substitution in the KCNQ1 gene in all of the family members affected with AF, but not in unaffected family members. Cell culture analyses confirmed that this genetic alteration disrupted the function of the KCNQ1 potassium channel.

The KCNQ1 potassium channel, like other ion channels, controls the electrical activity of the heart in excitable heart cells, or myocytes. "The mutation in KCNQ1 causes a marked enhancement of its function, tips the normal balance of the process, and renders the cardiac myocytes more susceptible to atrial fibrillation, explained lead authors Dr. Yi-Han Chen of Tongji University (Shanghai, China) and Dr. Shi-Jie Xu of the Chinese National Human Genome Center (Shanghai, China). "This new understanding of the molecular basis of atrial fibrillation may lead to better pre-symptomatic diagnosis of the disorder and to the development of new therapies.”


Related Links:
Tongji University
Chinese National Human Genome Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.